XYPIMCA
DEAD

Serial Number

79233971

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

XYPIMCA Trademark

Serial Number: 79233971 • Registration: 6060879

XYPIMCA is a trademark filed by NOVARTIS AG on March 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 24, 2018

Registration Date

May 26, 2020

Published for Opposition

July 31, 2018

Cancellation Date

August 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Aug 11, 2025 DETH
REGISTERED-PRINCIPAL REGISTER
May 26, 2020 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Apr 22, 2020 TMBN
USPTO CORRECTION PROCESSED BY IB
Jun 14, 2019 RINX
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
May 14, 2019 CORR
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
REG. CANCELLED - RESTORED TO PENDENCY
Jan 28, 2019 CRTP
ASSIGNED TO PETITION STAFF
Jan 25, 2019 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Jan 8, 2019 RCII
FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2019 FIMP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 28, 2018 TCCA
TEAS SECTION 7 REQUEST RECEIVED
Dec 28, 2018 ES7R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2018 TCCA
TEAS SECTION 7 REQUEST RECEIVED
Dec 21, 2018 ES7R
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 20, 2018 CRCV
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 20, 2018 GPAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 19, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 19, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2018 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 11, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 30, 2018 ETOF
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTICE OF PUBLICATION
Jul 11, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 7, 2018 SDRC